We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Famotidine, a heartburn medicine better known as Pepcid, has been added to the FDA’s drug shortage list shortly after it became known that the drug is being tested as a COVID-19 treatment. Read More
Incyte and Novartis are planning a second phase 3 clinical trial in the U.S. of their JAK inhibitor Jakafi (ruxolitinib) as a COVID-19 treatment. Read More
The FDA’s Center for Biologics Evaluation and Research (CBER) Director Peter Marks said Wednesday that he hopes the center can help expedite vaccine development to lead to a COVID-19 vaccine in nine months. Read More
The European Medicines Agency (EMA) said it will cut the review time for potential COVID-19 treatments and vaccines from 210 days to less than 150 days. Read More
Two lawmakers are pressing Jaguar Health to reverse the three-fold price hike on its diarrhea drug Mytesi (crofelemer) that has been considered as a possible COVID-19 treatment. Read More
Pfizer and BioNTech have started a U.S. trial of COVID-19 vaccine candidates at the NYU Grossman School of Medicine and the University of Maryland School of Medicine. Read More